---
figid: PMC8704013__nutrients-13-04503-g001
figtitle: Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate
  Cancer Progression
organisms:
- NA
pmcid: PMC8704013
filename: nutrients-13-04503-g001.jpg
figlink: /pmc/articles/PMC8704013/figure/nutrients-13-04503-f001/
number: F1
caption: 'Major cellular arginine metabolic routes and regulatory mechanisms. The
  aminoacid arginine is transported to the cell by CAT transporters or synthesized
  from citrulline. Intracellular arginine can either be metabolized by arginase I
  or II (ARGI or ARGII) to ornithine and urea (excreted out of the cell and of the
  body) or to NO and citrulline through iNOS catalysis, depending on iNOS/ARG ratio.
  ARGI expression and activity are regulated positively by anti-inflammatory and negatively
  via pro-inflammatory cytokines and NOHA, an intermediate in NO formation. In turn,
  iNOS activity is negatively regulated by agmatine, a decarboxylated product of arginine,
  and by anti-inflammatory cytokines, besides the positive pro-inflammatory and hypoxic
  stimulus. Preferential production of ornithine through ARG catalysis can either
  result in activation of the polyamines pathway (putrescine, spermidine, and spermine)
  or in ornithine shuttling to the mitochondria (where it might follow the pathway
  towards proline formation or be transformed in citrulline and shuttled back to the
  cytoplasm). Arginine antiported to the mitochondria will increase the ornithine
  pool after ARGII catalysis. When iNOS metabolizes arginine, the resulting products
  are citrulline and nitric oxide using BH4 as a co-factor. While NO might be transformed
  to peroxynitrite that may nytrosylate/nitrosate/nitrate key proteins to become pro-tumoral,
  citrulline formation will drive the ARG-NO recycling. Citrulline from UREA or ARG-NO
  cycles is converted to arginine-succinate (by ASS), which will result in arginine
  and fumarate (catalyzed by ASL). This last step represents a link with the Krebs
  cycle. Solid black lines with arrows indicate a positive effect, whereas solid lines
  with blunted ends specify an inhibitory effect. Dashed line indicates ornithine-citrulline
  antiport through mitochondrial membrane, whereas dotted line represents transportation
  of arginine into the mitochondria or transportation of P-5-C between cytoplasm and
  mitochondria. ASL, argininosuccinate lyase; ASS, argininosuccinate synthase; CPS-I,
  carbamoyl phosphate synthetase I; OAT, ornithine aminotransferase; ARG, arginase
  (type I and type II); ARG-NO cycle, arginine-nitric oxide cycle where iNOS is primarily
  involved in arginine metabolism; ADC, arginine decarboxylase; ODC, ornithine decarboxylase;
  OTC, ornithine transcarbamylase; iNOS, inducible nitric oxide synthase; L-HydroxyArg,
  L-hydroxyarginine; NO, nitric oxide; P-5-C, pyrroline-5-carboxylate; P5CR, pyrroline-5-carboxylate
  reductase; CAT1-3, cationic amino acid transporters (CAT1 is found in epithelial
  cells and CAT2 in macrophages); CCL2, Chemokine (C-C motif) ligand 2 or monocyte-chemoattractant
  protein 1; HIF1α, hypoxia-inducible factor 1 α; NFκB, nuclear factor κB; ORNT1,
  mitochondrial ornithine: citrulline antiporter; BH4, tetrahydrobiopterin; DCAM,
  decarboxylated 5-adenonosylmethionine; Glu, glutamate; MTA, methylthioadenosine;
  NOHA, N-hydroxy-L-arginine; α-KG, α-ketoglutamate; p53, tumor protein 53; Ras, Ras
  oncogene; COX-2, cyclooxygenase 2; PTEN, phosphatase and tensin homolog; UREA cycle,
  urea cycle where ARGI is primarily involved in arginine metabolism.'
papertitle: Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and
  Prostate Cancer Progression.
reftext: Andreia Matos, et al. Nutrients. 2021 Dec;13(12):4503.
year: '2021'
doi: 10.3390/nu13124503
journal_title: Nutrients
journal_nlm_ta: Nutrients
publisher_name: MDPI
keywords: arginine | arginase | metabolism | nitric oxide | prostate cancer | tumor
  microenvironment
automl_pathway: 0.9159462
figid_alias: PMC8704013__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8704013__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8704013__nutrients-13-04503-g001.html
  '@type': Dataset
  description: 'Major cellular arginine metabolic routes and regulatory mechanisms.
    The aminoacid arginine is transported to the cell by CAT transporters or synthesized
    from citrulline. Intracellular arginine can either be metabolized by arginase
    I or II (ARGI or ARGII) to ornithine and urea (excreted out of the cell and of
    the body) or to NO and citrulline through iNOS catalysis, depending on iNOS/ARG
    ratio. ARGI expression and activity are regulated positively by anti-inflammatory
    and negatively via pro-inflammatory cytokines and NOHA, an intermediate in NO
    formation. In turn, iNOS activity is negatively regulated by agmatine, a decarboxylated
    product of arginine, and by anti-inflammatory cytokines, besides the positive
    pro-inflammatory and hypoxic stimulus. Preferential production of ornithine through
    ARG catalysis can either result in activation of the polyamines pathway (putrescine,
    spermidine, and spermine) or in ornithine shuttling to the mitochondria (where
    it might follow the pathway towards proline formation or be transformed in citrulline
    and shuttled back to the cytoplasm). Arginine antiported to the mitochondria will
    increase the ornithine pool after ARGII catalysis. When iNOS metabolizes arginine,
    the resulting products are citrulline and nitric oxide using BH4 as a co-factor.
    While NO might be transformed to peroxynitrite that may nytrosylate/nitrosate/nitrate
    key proteins to become pro-tumoral, citrulline formation will drive the ARG-NO
    recycling. Citrulline from UREA or ARG-NO cycles is converted to arginine-succinate
    (by ASS), which will result in arginine and fumarate (catalyzed by ASL). This
    last step represents a link with the Krebs cycle. Solid black lines with arrows
    indicate a positive effect, whereas solid lines with blunted ends specify an inhibitory
    effect. Dashed line indicates ornithine-citrulline antiport through mitochondrial
    membrane, whereas dotted line represents transportation of arginine into the mitochondria
    or transportation of P-5-C between cytoplasm and mitochondria. ASL, argininosuccinate
    lyase; ASS, argininosuccinate synthase; CPS-I, carbamoyl phosphate synthetase
    I; OAT, ornithine aminotransferase; ARG, arginase (type I and type II); ARG-NO
    cycle, arginine-nitric oxide cycle where iNOS is primarily involved in arginine
    metabolism; ADC, arginine decarboxylase; ODC, ornithine decarboxylase; OTC, ornithine
    transcarbamylase; iNOS, inducible nitric oxide synthase; L-HydroxyArg, L-hydroxyarginine;
    NO, nitric oxide; P-5-C, pyrroline-5-carboxylate; P5CR, pyrroline-5-carboxylate
    reductase; CAT1-3, cationic amino acid transporters (CAT1 is found in epithelial
    cells and CAT2 in macrophages); CCL2, Chemokine (C-C motif) ligand 2 or monocyte-chemoattractant
    protein 1; HIF1α, hypoxia-inducible factor 1 α; NFκB, nuclear factor κB; ORNT1,
    mitochondrial ornithine: citrulline antiporter; BH4, tetrahydrobiopterin; DCAM,
    decarboxylated 5-adenonosylmethionine; Glu, glutamate; MTA, methylthioadenosine;
    NOHA, N-hydroxy-L-arginine; α-KG, α-ketoglutamate; p53, tumor protein 53; Ras,
    Ras oncogene; COX-2, cyclooxygenase 2; PTEN, phosphatase and tensin homolog; UREA
    cycle, urea cycle where ARGI is primarily involved in arginine metabolism.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JIL-1
  - egr
  - Dif
  - dl
  - Rel
  - tgo
  - sima
  - Aldh
  - Aldh-III
  - Inos
  - Nos
  - p53
  - betaTub60D
  - hth
  - ras
  - Ras64B
  - Ras85D
  - .na.character
  - COX2
  - MTA1-like
  - MtnA
  - CycE
  - cyc
  - Cam
  - asl
  - Ass
  - dpp
  - gbb
  - put
  - mav
  - P5cr
  - Oat
  - ATPsynbeta
  - Atpalpha
  - IL1A
  - IL1B
  - TNF
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - HIF1A
  - SETD2
  - ARNT
  - ALDH1A1
  - ALDH1A2
  - ALDH1A3
  - ALDH2
  - ALDH3A1
  - ALDH3A2
  - ALDH3B1
  - ALDH5A1
  - ALDH7A1
  - ALDH9A1
  - NOS2
  - ISYNA1
  - CCL2
  - TP53
  - TP63
  - TP73
  - KRAS
  - HRAS
  - NRAS
  - AZIN2
  - GADL1
  - PTGS2
  - CRAT
  - SLC7A1
  - TRPV6
  - SLC7A2
  - GIT2
  - TRPV5
  - SLC7A3
  - ASL
  - ADSL
  - ASS1
  - IL10
  - IL13
  - TGFB1
  - TGFB2
  - TGFB3
  - IL4
  - ODC1
  - SLC25A21
  - PYCR1
  - SLC25A15
  - OAT
  - ATP8A2
---
